NASDAQ: EXOZExozymes Inc Stock Ownership - Who owns Exozymes?
Insider buying vs selling
Have Exozymes Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Tyler Paz Korman | Chief Scientific Officer | 2026-04-09 | 750 | $10.53 | $7.89kSell |
| Tyler Paz Korman | Chief Scientific Officer | 2026-04-08 | 750 | $10.04 | $7.53kSell |
| Tyler Paz Korman | Chief Scientific Officer | 2026-04-01 | 5,332 | $8.44 | $45.00kBuy |
| Fouad Nawaz | Vice President- Finance | 2026-04-01 | 5,999 | $8.44 | $50.63kBuy |
| Paul Hideo Opgenorth | Vice President Development | 2026-04-01 | 3,999 | $8.44 | $33.75kBuy |
| Damien Alan Perriman | Chief Commercial Officer | 2026-04-01 | 8,887 | $8.44 | $75.01kSell |
| Michael Heltzen | Chief Executive Officer | 2025-07-02 | 1,040 | $10.22 | $10.63kBuy |
EXOZ insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EXOZ insiders and whales buy or sell their stock.
EXOZ Shareholders
What type of owners hold Exozymes Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Christopher A. Marlett | 44.92% | 3,808,476 | $27.99M | Insider |
| Mdb Capital Holdings LLC | 44.92% | 3,808,476 | $27.99M | Insider |
| Anthony Digiandomenico | 44.92% | 3,808,476 | $27.99M | Insider |
| Tyler Paz Korman | 8.60% | 729,123 | $5.36M | Insider |
| Paul Hideo Opgenorth | 7.61% | 645,149 | $4.74M | Insider |
| James Ulrich Bowie | 6.82% | 577,910 | $4.25M | Insider |
| Mohammad Hayat | 1.84% | 155,818 | $1.15M | Insider |
| Edgardo Javier Rayo | 0.92% | 77,909 | $572.63k | Insider |
| Damien Alan Perriman | 0.74% | 62,759 | $461.28k | Insider |
| Vanguard Capital Management LLC | 0.26% | 22,190 | $163.10k | Institution |
EXOZ vs Biotech Stocks
Exozymes Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.